Sofia Grigoriadou

8.9k citations
81 papers · 6.5k · 6 hit papers · h-index 34

Impact in

  • Immunology top 0.5%
    • Immunodeficiency and Autoimmune Disorders
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Immunodeficiency and Autoimmune Disorders 24
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 13

Sofia Grigoriadou

78 papers receiving 6.3k citations

Sofia Grigoriadou's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+4+9Years since publication100200300400500

Peers

Sofia Grigoriadou
Comparison fields: 5 of 101
  • Immunology 1.5k
  • Infectious Diseases 1.2k
  • Genetics 353
  • Genetics 542
  • Applied Microbiology and Biotechnology 31
Replace Sinisa Savic with:
Sinisa Savic United Kingdom
Aarnoud P. Huissoon United Kingdom
Matthew S Buckland United Kingdom
Stephen R.A. Jolles United Kingdom
Manel Juan Spain
Scott J. Hackett United Kingdom
Leslie S. Kean United States
Andrew M. Leader United States
Stefano Volpi Italy
Sophie Caillat‐Zucman France
Sofia Grigoriadou relative to Sinisa Savic United Kingdom Sinisa Savic's profile →
Citations per field
00.5×2×3.0×
Sinisa Savic · 1×
Citations per year

Countries citing papers authored by Sofia Grigoriadou

Since Specialization
Citations

This map shows the geographic impact of Sofia Grigoriadou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Grigoriadou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Grigoriadou more than expected).

Fields of papers citing papers by Sofia Grigoriadou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Grigoriadou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Grigoriadou. The network helps show where Sofia Grigoriadou may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofia Grigoriadou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofia Grigoriadou Line = papers co-authored together Sofia Grigoriadou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A robust model for read count data in exome sequencing experiments and implications for copy number variant calling
Hit paper breakdown →
2012584
2 2019456
3
Whole-genome sequencing of patients with rare diseases in a national health system
Hit paper breakdown →
2020418
4
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
5
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021393
6 2016382
7 2009334
8
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
9
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022231
10 2021213
11 2020181
12 2020179
13 2019178
14 2018174
15 2010148
16 2011132
17 2021125
18 2014118
19 2017114
20 2020101

About Sofia Grigoriadou

Sofia Grigoriadou is a scholar working on Immunology, Genetics, Infectious Diseases, Physiology and Genetics, having authored 81 papers that have together received 6.5k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (24 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), COVID-19 Clinical Research Studies (11 papers), Salivary Gland Disorders and Functions (6 papers), Pulmonary Hypertension Research and Treatments (2 papers), Kawasaki Disease and Coronary Complications (2 papers), Retinal Development and Disorders (2 papers) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Immunology (1.5k citations), Infectious Diseases (1.2k citations), Genetics (353 citations), Genetics (542 citations) and Applied Microbiology and Biotechnology (31 citations). Sofia Grigoriadou has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Hilary J Longhurst, Matthew S Buckland, Sergey Nejentsev, Kin Ying Mok, Sophie Hambleton, Rainer Döffinger, Vincent Plagnol, Adrian James Thrasher, Siobhan Oisin Burns and Michael R. Epstein. Their work appears in journals such as Clinical & Experimental Immunology, Journal of Allergy and Clinical Immunology, The Lancet, The American Journal of Human Genetics and Journal of Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact